Mark Your Calendar for BPI Europe 2025
12-15 May 2025Congress Center Hamburg, Germany Mark DuerkopChief Executive Officer at NovasignSpeaker
Profile
Dr. Mark Duerkop is co-founder and CEO of Novasign GmbH a spin-off from the University of Natural Resources and Life Sciences in Vienna focusing on accelerating bioprocess development by application of advanced machine learning tools. Within the last years Mark developed a hybrid modeling software with his team that help bioprocess engineers to better understand their processes while additionally reducing the experimental effort to find process optima.
Agenda Sessions
Chairperson's Opening Remarks: Intensified & Continuous Processing
, 08:55View SessionIntensified Design of Experiments: A Lean Approach to Accelerate Upstream Process Characterization
, 10:00View Session